NewsRoom Articles - Page 46 of 256

ThursdayJul 01, 2021 9:30 am

Golden Triangle Ventures Inc. (GTVH) Announces Acquisition of Wine/Olive Oil Co., Plan to Launch Products for World to Enjoy

GTVH closes on acquisition of the Lodge Winery & Olive Oil Co. under the company’s Food & Wine Division, Napa Wine Brands Inc. Included in the acquisition is a wide range of brands and products. Company committed to broaden horizon of food and wine company by creating a platform different than anything seen in the northern hemisphere. Golden Triangle Ventures (OTC: GTVH) is making a strong statement about its confidence in the $67-billion U.S. wine industry (https://cnw.fm/d3vnX) with its recent acquisition announcement. In May, the company acquired the Lodge Winery & Olive Oil Co. under the company’s Food & Wine…

ThursdayJul 01, 2021 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) (CSE: LXX) Announces Status Report on Six Key R&D Programs

Lexaria announced significant strides in six of its studies within the 2021 applied R&D program All the studies are based on Lexaria’s DehydraTECH(TM) technology and are designed for multiple market applications, including oral nicotine, NSAIDs, antivirals, and hypertension The 2021 applied R&D program is intended to generate not only confirmatory results and data evidencing but also foster strategic commercial opportunities and corporate relationships Lexaria Bioscience (NASDAQ: LEXX) (CSE: LXX) released a status report on six of its studies in the 2021 applied research and development (“R&D”) program. The program mainly involves studies using DehydraTECH(TM) 2.0 formulations, with different market areas…

WednesdayJun 30, 2021 2:16 pm

XPhyto Therapeutics Corp.’s (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Mescaline Program for Psychedelic Therapies is on Track

XPhyto Therapeutics Corp (OTCQB: XPHYF) announced its GMP mescaline synthesis program is “on schedule” The program, which started in early 2021, is slated for completion in late Q3 2021 The first initial production batches were completed successfully, marking a significant milestone for the program Mescaline will form a critical component in XPhyto’s psychedelic medicine program and work towards providing a foundation for its drug formulation and clinical validation work XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) recently announced that its Good Manufacturing Practices (“GMP”) mescaline synthesis program in North America is “on schedule” for completion in late Q3 2021…

WednesdayJun 30, 2021 1:54 pm

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Ships Initial Order of 0.5 Gram Vape Cartridges

Pure Extracts announced initial shipment of 0.5 gram vape cartridges to Alberta Gaming, Liquor & Cannabis CBD vape market has experienced strong growth in recent times, with one market research firm forecasting sector to be worth over $28bn by 2027 Pure Extracts has simultaneously sought to broaden its SKU’s within vape sector, commencing manufacture of larger, 1 gram FSO vape cartridge to better cater to changing customer demand patterns Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on the cannabis, hemp, functional mushrooms, and rapidly emerging psychedelic sector, announced that its whole owned subsidiary,…

WednesdayJun 30, 2021 11:26 am

Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) Leading Out in Quest for Elusive Cannabis Prize

Cannabis space facing “critical moment” as consumers seek proven consistency Pac Roots partner, business model assists in commitment to deliver “predictable, reliable product” Pac Roots ideally positioned to preserve excellence of its elite strains while also introducing highest quality of new strains The cannabis industry has reached a crossroads of sorts, according to a recent “New York Times” article, as the substance has become increasingly mainstream. While welcome, the popularity of cannabis presents a challenge that companies such as Pac Roots Cannabis (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) are eager to meet. “The cannabis business, then, has arrived at a critical moment,”…

TuesdayJun 29, 2021 12:25 pm

Golden Triangle Ventures Inc. (GTVH) Finalizes Acquisition of Syndicate Bass Records, Announces Launch Event for Label

Acquisition enables GTVH, Lavish Entertainment to debut experimental bass music record label Hard Rock Live event spotlights artists that are releasing music on the Syndicate Bass Records label Company has built reputation for providing intricate, complex sounds; spotlighting artists from around the world Golden Triangle Ventures (OTC: GTVH) and its subsidiary Lavish Entertainment have completed an acquisition that enables the company to debut its own experimental bass music record label (https://cnw.fm/MwcaB). GTVH and its entertainment division signed off on the acquisition of Syndicate Bass Records LLC, a label collection curated by individuals who strongly believe in the impact of the…

TuesdayJun 29, 2021 9:32 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) (CSE: LXX) Is ‘One to Watch’

Lexaria Bioscience Corp. has disruptive proprietary technology protected by a broad international patent portfolio The company has been issued 19 patents in the U.S., European Union and other countries, with more than 50 patents pending around the world Lexaria’s DehydraTECH technology has a vast worldwide, multi-billion-dollar total addressable market, including multiple rapid-growth segments like cannabinoid and noncombustible nicotine delivery The company has licensed its fat-soluble active molecule delivery technology to multiple established companies for use in their products Lexaria completed an uplisting to Nasdaq Capital Markets and an $11 million financing in January 2021 Lexaria Bioscience (NASDAQ: LEXX) (CSE: LXX)…

MondayJun 28, 2021 2:57 pm

HempFusion Wellness Inc. (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO) Marks a Significant Milestone in its European Expansion Plan; Announces New Chief Financial Officer

HempFusion Wellness Inc. announces it is offering its new EU-compliant products through Boots Ireland This marks the company’s official entry into the Irish market in what is a significant step in further venturing into the U.K. and Europe as a whole Boots will carry HempFusion’s products in close to 50% of stores in the country Following unprecedented circumstances, HempFusion announced a new Chief Financial Officer, Ms. Maria Leal, taking over from Mr. Bruce Valentine Ms. Leal will oversee HempFusion’s finance and accounting functions HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO) just marked a significant milestone in its European expansion…

MondayJun 28, 2021 12:51 pm

Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) Ready as Ottawa Review of Federal Cannabis Act Approaches

Canadian lawmakers are scheduled to assemble during Q4 to assess past, current, future state of legal cannabis market Pac Roots Cannabis has quietly positioned itself as an integrated producer of premium cannabis and hemp Pac Roots is generating revenue through a hemp JV, has access to exclusive cultivars, is completing a production facility, has an agreement for more land and recently bought an established cannabis lifestyle brand The Canadian government has taken a measured approach to legalization of marijuana, but now nearly three years in, advocates will be looking at meaningful progress with regards to regulations to support the industry…

FridayJun 25, 2021 2:19 pm

RYAH Group Inc. (CSE: RYAH) Cannabis Clinical Trials Improve Due to Dose-Measuring Devices

Cannabis is a chemically variable plant making its clinical trials problematic, before the creation of dose-measuring devices RYAH Smart inhalers being used in one of the largest clinical studies of its kind focused on chronic pain Restrictive funding and legislative barriers regarding cannabis are rapidly dissipating Regulating dose size in cannabis clinical trials has proven problematic from one test subject to another because cannabis is a chemically variable plant. RYAH Group (CSE: RYAH), a health care analytics and technology company, has created IoT dose-measuring devices backed by powerful data analytics, allowing for more control for variables within a clinical setting. …

News and publishing service for CBD related companies

Contact us: 512.354.7000